Skip to main content

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010) / Chapter Skim
Currently Skimming:

Appendix E: Workshop Agenda
Pages 305-306

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 305...
... Appendix E Workshop Agenda Institute of Medicine Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Meeting 2 Workshop The Keck Center of The National Academies 500 Fifth Street, NW Washington, DC 20001 April 6, 2009 OPEN SESSION 8:00 am Breakfast 8:30 am Welcome and Opening Remarks John Ball, Committee Chair 9:00 am Analysis of Task -- General Guidance -- Robert Temple 10:00 am BREAk 10:15 am Quantitative Decision Analytical Modeling Tools -- Rebecca Miksad 11:15 am Existing Frameworks for Biomarker Qualification -- CDER -- Marc Walton and Aliza Thompson 12:15 pm BREAk 12:30 pm LuNCH -- Analogous Environment -- Process Standards for Manufacturing, Businesses -- David Dilts 0
Read the entire page →
From page 306...
... 0 EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS 1:30 pm Existing Frameworks for Biomarker Qualification -- PhRMA -- James Mayne 2:00 pm NIH Biomarker Qualification/Cancer Perspective -- Arthur Schatzkin 2:30 pm Risk Factor to Surrogate Endpoint Pathway -- Philip Greenland 3:00 pm Discussion 3:30 pm BREAk 3:45 pm Troponin -- James de Lemos -- James James 4:15 pm CRP and Inflammatory Markers -- Christie Ballantyne 4:45 pm HDL/LDL -- Bryan Brewer 5:15 pm Case Studies Discussion Speakers and Committee 5:45 pm ADJOuRN
Read the entire page →

Key Terms



This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.